MedTrace Logo

Active Surveillance of the Small Renal Mass

NCT02204800 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2021-03-01

No results posted yet for this study

Summary

Active surveillance in kidney cancer involves closely observing the tumor with periodic imaging studies rather than immediately proceeding to an invasive treatment. This does not mean that the tumor is ignored or that future treatment is not necessary, rather it means the tumor does not require treatment at this time. On active surveillance, a tumor is closely monitored without treatment, however if the tumor changes and reaches a predefined threshold that your physician no longer considers safe, your physician will strongly encourage treatment.

Conditions

  • Small Renal Mass, Kidney Cancer

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Brian Shuch, MD · Yale University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2020-08-31
Completion
2020-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02204800 on ClinicalTrials.gov